ÐÂÎŶ¯Ì¬
ÔÚÓлúºÏ³ÉÖУ¬Ëá°·ËõºÏ·´Ó¦ÊÇÒ»ÖÖ³£¼ûµÄ»¯Ñ§×ª»¯£¬ÆäÖÐõ£°·¼ü²»µ«ÔÚÖÚ¶à×ÔÈ»ÎïÖʺÍÈ˹¤ºÏ³ÉÖÊÁÏÖÐÆÕ±é±£´æ£¬ÕÕ¾É×é³ÉÐí¶àÒ©Îï·Ö×ӺͶàëÄÁ´µÄ½¹µã¹ÙÄÜÍÅ¡£ÌáÆðõ£°·¼üµÄ¹¹½¨£¬ËõºÏ¼ÁµÄ½ÇÉ«ÏÔµÃÓÈΪÖ÷Òª¡£Êг¡ÉÏÒÑÓÐÁÖÁÖ×Ü×ܵÄËõºÏÊÔ¼Á¿É¹©Ñ¡Ôñ£¬°üÀ¨Ì¼¶þÑǰ·ÀàÈçDCC¡¢DICºÍEDCI£»æfÑÎÀ࣬ÈçHATU¡¢HBTUºÍPyBroP£»ÓлúÁ×»¯ºÏÎÈçT4PºÍDPPA£»ÒÔ¼°ÈýàºÀ࣬ÈçCDMTºÍDMTMMµÈ¡£Ö»¹ÜÕâЩËõºÏ¼ÁÔÚ¸÷×ÔÊÊÓõÄõ£»¯·´Ó¦ÖÐÌåÏÖ¾«²Ê£¬µ«ÃæÁÙ´óλ×èôÈËá»ò»îÐÔ²»¸ßµÄ°·Ààµ×Îïʱ£¬Ðí¶àËõºÏÊÔ¼ÁµÄЧ¹ûÍùÍù»á´ó´òÕÛ¿Û¡£
N,N,N',N'-Ëļ׻ùÂȼ×ëßÁù·úÁ×ËáÑΣ¬¼ò³ÆTCFH£¬ËüÊÇÒ»ÖÖÂÌÉ«µÄ¶à¹¦Ð§ËõºÏÊÔ¼Á£¬ÓÈÆäÉÆÓÚ´óλ×èôÈËáÓë·Ç»îÐÔ°·Ö®¼äµÄËõºÏ·´Ó¦£¬ÓÐÓÃÍ»ÆÆÁËÐí¶àͬÀàÊÔ¼ÁÔÚ´ËÀà·´Ó¦ÖеľÖÏÞÐÔ¡£TCFHÓëÆäËûÊÔ¼Á×éºÏ¿ÉÒÔÐγÉõ£ÂÈ£¬Ëáôû£¬õ£»ùßäßòµÈ»îÐÔÖÐÐÄÌ壬½ø¶øÊµÏÖõ£°·¼ü»òõ¥¼üµÄ¸ßЧ¹¹½¨¡£
ÔÚÓлúºÏ³ÉºÍÒ©Î↑·¢ÖУ¬TCFHͨ³£×÷ΪһÖÖÔλÌìÉúõ£ÂȵÄËõºÏÊÔ¼Á£¬ÒÔßßàºÃ¹ËØA£¨piperazimycin A£©µÄºÏ³ÉΪÀý£¬Í¨¹ýTCFHÓëôÈËáÌìÉúõ£ÂÈ£¬½ø¶øÔö½øßßàºËáÖ®¼äµÄżÁª£¬Õ¹Ê¾ÁËÆäÔںϳÉÖØ´ó·Ö×ÓÖеÄÓ¦ÓÃDZÁ¦¡£
TCFH²»µ«×Ô¼ºÊÇÒ»ÖÖÓÐÓõÄËõºÏÊÔ¼Á£¬Í¬Ê±Ò²ÊÇÐí¶àÖØ´óËõºÏÊÔ¼ÁµÄǰÌ壬ÈçTFFH£¬HBTUµÈ¡£
¸üÖ÷ÒªµÄÊÇ£¬TCFHÓë²î±ð¼îµÄ×éºÏ¿ÉÒÔÇáËÉʵÏÖÒÔ´óλ×èËáºÍ·Ç»îÐÔ°·Îªµ×ÎïµÄËõºÏ·´Ó¦¡¢´ó»·ÄÚõ¥ÒÔ¼°Áòõ¥µÄºÏ³É¡£
ÔÚ¹¹½¨õ£°·¼ü·½Ã棬TCFHÌØÊâÉÃÓŵãÀíÄÇЩλ×è½Ï´ó»òÇ׺ËÐÔ²»Ç¿µÄ°·À໯ºÏÎÀýÈ磬ÔÚpan-RAFÒÖÖÆ¼ÁBelvarafenibµÄºÏ³É¹¤ÒÕÖУ¬TCFHÔÚ×îÖÕµÄżÁª°ì·¨ÖÐÏÔʾ³öÁËÓÅÒìµÄÐÔÄÜ£¬±»ÒÔΪÊÇ×î¼ÑµÄËõºÏÊÔ¼Á¡£
±ðµÄ£¬Gregory L. BeutnerÍŶӶÔTCFH-NMIÕâÒ»×éºÏ¾ÙÐÐÁ˽ÏÁ¿ÉîÈëµÄÑо¿£¬Õ¹ÏÖÁËÕâÒ»×éºÏÔÚËá°·ËõºÏ·´Ó¦ÖеÄ׿ԽÐÔÄÜ£¬ÏêÇéÇë²ÎÔÄÎÒ˾ÏÈǰÐû²¼µÄÎÄÕ¡°¸ßЧËá°·ËõºÏµÄ»Æ½ð×éºÏ£ºTCFH-NMI¡±¡£
»úе»¯Ñ§ºÏ³ÉÊÇÒ»ÖÖÎÞÈܼÁ£¬·´Ó¦ËÙÂÊ¿ìÇÒÊèÉ¢Àû±ãµÄÇкϿÉÒ»Á¬Éú³¤µÄÂÌÉ«ºÏ³ÉÒªÁì¡£Riina AavÍŶӿª·¢ÁËÒ»ÖÖ»ùÓÚTCFH-K2HPO4ºÍTCFH-NMIϵͳµÄ»úе»¯Ñ§ºÏ³É·¨£¬¿ÉÒÔ¸ßЧµÄʵÏÖõ£°·¼üµÄ¹¹½¨£¬²¢ÇÒ¶ÔÁÚλÁ¢ÌåÖÐÐĵÄÓ°Ïì΢ºõÆä΢¡£
TCFHÕ¹ÏÖÁËÆäÔÚ»¯Ñ§ºÏ³ÉÁìÓòÖÐÆÕ±éµÄ»¯Ñ§»îÐԺͶàÑù»¯µÄÓ¦ÓÃDZÁ¦¡£ÔÚõ¥»¯·´Ó¦ÖУ¬ TCFH-Pyϵͳ¾ßÓкܸߵķ´Ó¦»îÐÔ£¬Í¨¹ýÐγÉËáôû»îÐÔÖÐÐÄÌ壬¸ßЧµØÖƱ¸Ä¿µÄõ¥À໯ºÏÎï¡£
±ðµÄ£¬TCFH»¹ÄÜÓ¦ÓÃÓÚÁòõ¥ºÍ´ó»·ÄÚõ¥µÄºÏ³ÉÖУ¬½øÒ»²½Ö¤ÊµÎúÆäÔÚÓлúºÏ³ÉÁìÓòÖеÄÖ÷Òª¼ÛÖµ¡£
Áòõ¥µÄºÏ³É£º
´ó»·ÄÚõ¥µÄºÏ³É£º
×ܵÄÀ´Ëµ£¬TCFHÊÇÒ»ÖÖÓ¦ÓÃÆÕ±éµÄËõºÏÊÔ¼Á£¬¾ßÓиßЧºÏ³Éõ£°·ºÍõ¥À໯ºÏÎïµÄÄÜÁ¦¡£¸ÃÊÔ¼Á¿ÉÒÔÓë²î±ðµÄÌí¼Ó¼ÁÎÞа´îÅ䣬ͨ¹ýµ÷½âÊÔ¼ÁÅä±ÈºÍ·´Ó¦Ìõ¼þ£¬ÒÔʵÏÖ×î¼ÑµÄ·´Ó¦Ð§¹û£¬½µµÍ²îÏòÒì¹¹»¯µÈ¸±·´Ó¦µÄ±¬·¢£¬Îª¿ÆÑÐÊÂÇéÖ°Ô±ÌṩÁ˸ü¶à¿É¹©Ñ¡ÔñµÄºÏ³É¼Æ»®¡£
×÷ΪȫÇòÁìÏȵĶàëĺϳÉÊÔ¼Á¹©Ó¦ÉÌ£¬ÎÒÃÇÖÂÁ¦ÓÚΪ¿Í»§Ìṩ¸ßÆ·ÖÊ¡¢¹æ¸ñ¶àÑùµÄTCFHÊÔ¼Á¡£Í¬Ê±£¬ÎÄÖÐÌáµ½µÄµÚÒ»´úÖÁµÚËÄ´úËõºÏÊÔ¼ÁÎÒ˾¾ùÓÐÔÚÊÛ£¬¿ÉÒÔÖª×ã²î±ð¿Í»§µÄ¶àÑù»¯ÐèÇ󣬽ӴýÓÐÐèÇóµÄÅóÙÀ´µç´¹Ñ¯¡£
²Î¿¼ÎÄÏ×£º
[1] Kennedy, J.P.; Lindsley, C.W. Progress towards the synthesis of piperazimycin A: synthesis of the non-proteogenic amino acids and elaboration into dipeptides[J]. Tetrahedron Lett. 2010,51,2493-2496.
[2] Zell, D.; Dalziel, M.E.; Gosselin, F.; et al. An Efficient Second- Generation Manufacturing Process for the pan-RAF Inhibitor Belvarafenib[J]. Org. Process Res. Dev. 2021, 25, 2338-2350.
[3] Beutner, G.L.; Young, I.S.; Ye, Q.M.; et al. TCFH?NMI: Direct Access to N?Acyl Imidazoliums for Challenging Amide Bond Formations[J]. Org. Lett. 2018, 20, 4218-4222.
[4] Dalidovich, T.; Mishra, K.A.; Aav, R.; et al. Mechanochemical Synthesis of Amides with Uronium-Based Coupling Reagents: A Method for Hexa-amidation of Biotin[6]uril[J]. ACS Sustainable Chem. Eng. 2020, 8, 15703-15715.
[5] Luis, N.R..; Chung, K.K.; Vosburg, D.A.; et al. Beyond Amide Bond Formation: TCFH as a Reagent for Esterification[J]. Org. Lett. 2023.
[6] De La Rosa, M.A.; Miller, J.F.; Samano, V.; et al. Compounds useful in HIV therapy. WO 2020178767 A1, 2020.